Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Earnings Report Date & History

Out of the last 4 earnings reporting periods, Lakewood-Amedex Biotherapeutics Inc. Common Stock beat analysts’ expectations 2 times and fell short of expectations 1 time(s). Lakewood-Amedex Biotherapeutics Inc. Common Stock reported earnings per share of in the last report surpassing an estimated EPS of -$ 1.33 by -100.00%.

Lakewood-Amedex Biotherapeutics Inc. Common Stock’s stock was trading at $ 0.395 on Nov 11, 2026 a day before the last earnings report was released.Following the release of the earnings report, LABT’s price decreased to $ 0.2824 on Nov 13, 2026, recording a -28.51% price change in the 48-hour period.

When does Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) report earnings?

Lakewood-Amedex Biotherapeutics Inc. Common Stock released its most recent earnings reports in November 2026, September 2026, August 2026, May 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.

What is Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) stock EPS forecast?

Lakewood-Amedex Biotherapeutics Inc. Common Stock beat analysts’ expectations during the last earnings period by -100.00%. Lakewood-Amedex Biotherapeutics Inc. Common Stock reported earnings of per share on Nov 12, 2026, while the forecasted EPS was -$ 1.33